Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > AGM

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Mar 10, 2023 9:28am

58 Views

Post# 35330191

RE:RE:AGM

What percentages of votes a board member needs to keep his job by the way. If we vote the board out or a couple of members how do we replace them and afterwards how do we adress the management aircut and replacement. This company needs Luc Tanguay back at any cost at the moment to regain credibility, both Levesque and Dubuc must go.

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment